“The Influence of Chronic Disease Development Sequence on Long COVID Risk: Insights from a Large Population Study in Catalonia”

The recent study from the Germans Trias i Pujol Research Institute in Barcelona reveals that the sequence in which individuals develop chronic conditions before contracting COVID-19 profoundly influences the likelihood of experiencing long COVID. This analysis, based on data from 8,322 adults in Catalonia, Spain, shows that not just the presence of chronic diseases, but their order of onset, can predict long COVID risk. This finding complements growing evidence of how pre-existing health impacts the persistent, often debilitating, symptoms seen in COVID-19 survivors.

Sequence of Chronic Conditions and Long COVID Risk

Published in BMC Medicine in early November 2025, the study reconstructed disease trajectories using electronic health records over a decade (2010-2019) preceding the pandemic. Researchers identified 162 distinct pairs of chronic conditions occurring in sequence; of these, 38 pairs were linked with significantly higher risk of long COVID regardless of infection severity. Common trajectories implicated mental health disorders alongside neurological, respiratory (e.g., asthma), metabolic, and digestive diseases (e.g., hypertension, obesity). The lead author, Natalia Blay, highlighted that the order in which these conditions develop affects long COVID risk with notable variation between sexes, especially increased risk among women.​

Context and Background on Long COVID and Chronic Conditions

Long COVID is characterized by persistent symptoms such as fatigue, cognitive impairment, muscle pain, and respiratory difficulties lasting weeks to months beyond acute infection. The Mayo Clinic and other authorities recognize it as a chronic condition triggered by SARS-CoV-2 infection attacking multiple organ systems. Prior studies have established that individuals with pre-existing conditions—especially respiratory diseases like asthma and COPD—are more vulnerable to long-term COVID-19 sequelae. A notable meta-analysis covering 43 epidemiologic studies revealed that asthma increased odds of long COVID by 41%, while COPD raised odds by 32%, including chronic fatigue symptoms in asthma patients.​

Expert Commentary on Implications

Dr. Maria Serrano, a pulmonologist not involved in the study, remarked, “Understanding the sequence of chronic illnesses offers a new lens to predict and possibly prevent long COVID. Chronic inflammation and immune dysregulation from prior conditions likely set the stage for persistent symptoms after infection. Tailored follow-up for people with certain disease trajectories is crucial.” Other experts emphasize the need for personalized medicine approaches, considering patients’ health history patterns rather than isolated conditions.​

Public Health and Practical Implications

This study underscores the importance of comprehensive chronic disease management—not only to improve baseline health but also to potentially reduce the risk of long-term complications from infections like COVID-19. For the general public, it stresses vigilance in managing chronic conditions early, seeking timely medical care for emerging symptoms, and maintaining preventive measures against COVID-19. Vaccination remains critical, as unvaccinated individuals have over twice the risk of long COVID compared to those vaccinated. Healthcare professionals should incorporate detailed patient histories of chronic disease trajectories into risk assessments and post-COVID care plans.​

Limitations and Considerations

While the study’s cohort design and large sample size strengthen its findings, limitations include potential unmeasured confounders and variability in long COVID definitions across studies. The reported associations do not confirm causality but highlight predictive patterns. The complexity of long COVID, possibly involving immune, neurological, and vascular mechanisms, means that additional biological research is needed to unravel underlying pathways. Furthermore, generalization beyond the studied population requires caution.​

Medical Disclaimer

This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References